RxDoctor Payments Data

John Adams, MD

Orthopaedic Trauma · Greenville, SCNPI 1629206255

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.5%), consulting fees and royalties or licence payments — rather than concentrated in one kind of arrangement. Arthrex accounts for 91.8% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $319,912, more than ten times the $26,985 reported in 2019.

$1,002,616in general payments, 2019–2025

Across 1,078 payments — averaging $930.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$920K
  • Smith+Nephew$44K
  • Stryker$21K
  • Synthes GmbH$7K
  • Peerless Surgical Inc.$5K
  • Medical Device Business Services, Inc.$2K
  • plus $3K from 10 others
$149,109in research payments, 2019–2025

Across 12 payments — averaging $12,426 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$149K

What the payments were for

  • Royalty or licence$85,6089%
  • Consulting fees$270,90627%
  • Speaking & faculty fees$556,66456%
  • Travel & lodging$64,2136%
  • Food & beverage$19,7772%
  • Education$5,4491%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic trauma providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$98,887
Medicare patients
117
Services billed
390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic trauma in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →